Deborah L Mangold1, Gary S Wand. 1. University of Texas at San Antonio, San Antonio, Texas 78249, USA. dmangold@utsa.edu
Abstract
BACKGROUND: Neuroticism is a highly heritable personality trait that is a risk factor for certain affective and anxiety disorders. Studies link neuroticism with alterations in the Hypothalamic-Pituitary-Adrenal (HPA) stress response. We interrogated HPA axis dynamics as a function of neuroticism, employing the opioid receptor antagonist, naloxone. METHODS: Subjects were assigned to either high or low neuroticism groups on the basis of Revised Neuroticism, Extraversion, Openness Personality Inventory (NEO-PI-R) scores and received naloxone hydrochloride (0, 125 microg/kg, and 375 microg/kg). Serum adrenocorticotropic hormone (ACTH) and cortisol levels were monitored. RESULTS: Significant, dose-dependent differences in cortisol response were observed between neuroticism groups, whereas no differences were observed in ACTH. The low neuroticism group demonstrated a dose-dependent cortisol response with a plateau at the 125 microg/kg dose of naloxone. In contrast, the high neuroticism group demonstrated a graded cortisol response to all doses of naloxone. CONCLUSIONS: These findings show that neuroticism is associated with altered cortisol responses to opioid receptor blockade, suggesting that alterations in HPA axis function already exist in persons at increased risk for certain depressive and anxiety disorders.
BACKGROUND: Neuroticism is a highly heritable personality trait that is a risk factor for certain affective and anxiety disorders. Studies link neuroticism with alterations in the Hypothalamic-Pituitary-Adrenal (HPA) stress response. We interrogated HPA axis dynamics as a function of neuroticism, employing the opioid receptor antagonist, naloxone. METHODS: Subjects were assigned to either high or low neuroticism groups on the basis of Revised Neuroticism, Extraversion, Openness Personality Inventory (NEO-PI-R) scores and received naloxone hydrochloride (0, 125 microg/kg, and 375 microg/kg). Serum adrenocorticotropic hormone (ACTH) and cortisol levels were monitored. RESULTS: Significant, dose-dependent differences in cortisol response were observed between neuroticism groups, whereas no differences were observed in ACTH. The low neuroticism group demonstrated a dose-dependent cortisol response with a plateau at the 125 microg/kg dose of naloxone. In contrast, the high neuroticism group demonstrated a graded cortisol response to all doses of naloxone. CONCLUSIONS: These findings show that neuroticism is associated with altered cortisol responses to opioid receptor blockade, suggesting that alterations in HPA axis function already exist in persons at increased risk for certain depressive and anxiety disorders.
Authors: Benjamin Chapman; Paul Duberstein; Hilary A Tindle; Kaycee M Sink; John Robbins; Daniel J Tancredi; Peter Franks Journal: Am J Geriatr Psychiatry Date: 2012-07 Impact factor: 4.105
Authors: Paul R Duberstein; Benjamin P Chapman; Hilary A Tindle; Kaycee M Sink; Patricia Bamonti; John Robbins; Anthony F Jerant; Peter Franks Journal: Psychol Aging Date: 2011-06
Authors: Gary S Wand; Elise M Weerts; Hiroto Kuwabara; Dean F Wong; Xiaoqiang Xu; Mary E McCaul Journal: Addict Biol Date: 2012-01-20 Impact factor: 4.280
Authors: A R Sutin; A Terracciano; B Deiana; S Naitza; L Ferrucci; M Uda; D Schlessinger; P T Costa Journal: Psychol Med Date: 2009-12-09 Impact factor: 7.723
Authors: Audrey R Tyrka; Lauren M Wier; Lawrence H Price; Kobita Rikhye; Nicole S Ross; George M Anderson; Charles W Wilkinson; Linda L Carpenter Journal: Horm Behav Date: 2008-02-21 Impact factor: 3.587
Authors: Ilan Dar-Nimrod; Benjamin P Chapman; John A Robbins; Anton Porsteinsson; Mark Mapstone; Paul R Duberstein Journal: Int J Geriatr Psychiatry Date: 2012-01-04 Impact factor: 3.485